Study Bolsters Statin Myocardial Infarction Prevention Evidence
This article was originally published in The Tan Sheet
Executive Summary
Use of statins and beta-blockers in individuals with no history of coronary disease may be correlated with a reduced risk of more serious cardiovascular events, a study in the Feb. 21 Annals of Internal Medicine finds
You may also be interested in...
FDA Mevacor OTC Switch Answer: Signs Point To “Not Approvable”
FDA appears to have issued a "not approvable" letter in response to J&J/Merck's application to switch the cholesterol-lowering drug Mevacor (lovastatin 20 mg) over the counter
Fraud Discovery Institute Asks Waxman To Address Lead In Herbalife Products
FDA should issue a public health alert to warn consumers about potential health risks that may result from use of Herbalife dietary supplements and should remove the company's products from the market, pending further investigation of lead contamination, according to Christopher Grell, an attorney whose firm specializes in ephedra and dietary supplement litigation
Fraud Discovery Institute Asks Waxman To Address Lead In Herbalife Products
FDA should issue a public health alert to warn consumers about potential health risks that may result from use of Herbalife dietary supplements and should remove the company's products from the market, pending further investigation of lead contamination, according to Christopher Grell, an attorney whose firm specializes in ephedra and dietary supplement litigation